Compare CRMD & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRMD | FRPH |
|---|---|---|
| Founded | 2006 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 590.7M | 420.6M |
| IPO Year | 2009 | 1995 |
| Metric | CRMD | FRPH |
|---|---|---|
| Price | $7.78 | $21.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.83 | N/A |
| AVG Volume (30 Days) | ★ 813.9K | 92.7K |
| Earning Date | 05-11-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $311,709,000.00 | $42,846,000.00 |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.75 | ★ N/A |
| Revenue Growth | ★ 617.03 | 2.57 |
| 52 Week Low | $6.13 | $20.53 |
| 52 Week High | $13.02 | $25.74 |
| Indicator | CRMD | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 43.48 | 41.42 |
| Support Level | $7.09 | $20.74 |
| Resistance Level | $9.01 | $23.10 |
| Average True Range (ATR) | 0.24 | 0.50 |
| MACD | -0.07 | -0.08 |
| Stochastic Oscillator | 14.22 | 31.41 |
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, industrial, and office (the Development Segment), and (iv) management of mixed-use residential/retail properties owned through joint ventures.